NFKB1 and melanoma: Permanent activation of NF-κB signaling in melanoma has been reported to proceed through the activation of the so-called canonical pathway (Yang and Richmond, 2001; Dhawan and Richmond, 2002; Amiri and Richmond, 2005; Amschler et al., 2010).